News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
90 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21902)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (138)
2 (86)
3 (59)
8 (97)
9 (101)
10 (84)
11 (105)
12 (56)
15 (90)
16 (125)
17 (106)
18 (118)
19 (57)
22 (108)
23 (101)
24 (100)
25 (139)
26 (75)
29 (161)
30 (126)
31 (159)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
8
9
10
11
12
15
16
17
18
19
22
23
24
25
26
29
30
31
Press Releases
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer
July 15, 2024
·
5 min read
Neuropsychiatric disorders
Ozempic Tied to Lower Risk of Dementia, Nicotine Misuse: Study
Despite recent concerns about suicidality and other neuropsychiatric issues, a recent study has found that Novo Nordisk’s Ozempic (semaglutide) is associated with lower risks of dementia, cognitive deficit and nicotine misuse.
July 15, 2024
·
2 min read
·
Tristan Manalac
Press Releases
I-Mab Announces Leadership Transitions
July 15, 2024
·
5 min read
Press Releases
Lupin Divests U.S. Commercial Women’s Health Specialty Business to Evofem, including SOLOSEC
July 15, 2024
·
5 min read
Press Releases
Lowcountry Oncology Associates Partners with OneOncology
July 15, 2024
·
2 min read
IPO
Metagenomi CSO Steps Down Shortly After IPO, Moderna Exit
Following a disappointing IPO and the loss of Moderna’s gene editing contract, Metagenomi’s Chief Scientific Officer Luis Borges is departing the biotech.
July 15, 2024
·
2 min read
·
Tristan Manalac
Press Releases
NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors
July 15, 2024
·
4 min read
Press Releases
GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research
July 15, 2024
·
8 min read
Press Releases
Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop
July 15, 2024
·
6 min read
Press Releases
Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
July 15, 2024
·
1 min read
Previous
5 of 9
Next
